Caspase-8: A novel target to overcome resistance to chemotherapy in glioblastoma

Giulia Fianco, Claudia Contadini, Alessandra Ferri, Claudia Cirotti, Venturina Stagni, Daniela Barilà

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Caspase-8 was originally identified as a central player of programmed cell death triggered by death receptor stimulation. In that context, its activity is tightly regulated through several mechanisms, with the best established being the expression of FLICE-like inhibitory protein (FLIP) family proteins and the Src-dependent phosphorylation of Caspase-8 on Tyr380. Loss of apoptotic signaling is a hallmark of cancer and indeed Caspase-8 expression is often lost in tumors. This event may account not only for cancer progression but also for cancer resistance to radiotherapy and chemotherapy. Intriguingly, other tumors, such as glioblastoma, preferentially retain Caspase-8 expression, and high levels of Caspase-8 expression may correlate with a worse prognosis, suggesting that in this context this protease loses its apoptotic activity and gains additional functions. Using different cellular systems, it has been clearly shown that in cancer Caspase-8 can exhibit non-canonical functions, including promotion of cell adhesion, migration, and DNA repair. Intriguingly, in glioblastoma models, Caspase-8 can promote NF-κB-dependent expression of several cytokines, angiogenesis, and in vitro and in vivo tumorigenesis. Overall, these observations suggest that some cancer cells may hijack Caspase-8 function which in turn promote cancer progression and resistance to therapy. Here we aim to highlight the multiple functions of Caspase-8 and to discuss whether the molecular mechanisms that modulate the balance between those functions may be targeted to dismantle the aberrant activity of Caspase-8 and to restore its canonical apoptotic functionality.

Original languageEnglish
Article number3798
JournalInternational Journal of Molecular Sciences
Volume19
Issue number12
DOIs
Publication statusPublished - Dec 1 2018

Fingerprint

Chemotherapy
Caspase 8
chemotherapy
Glioblastoma
cancer
Drug Therapy
Tumors
Neoplasms
progressions
Proteins
tumors
Phosphorylation
proteins
Cell adhesion
Radiotherapy
angiogenesis
Cell death
phosphorylation
protease
prognosis

Keywords

  • Apoptosis
  • Caspase-8
  • Chemotherapy and radiotherapy
  • DNA damage
  • FLIP
  • Glioblastoma
  • NF-κB
  • Src kinase
  • Tumor microenvironment
  • Tyrosine phosphorylation

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Caspase-8 : A novel target to overcome resistance to chemotherapy in glioblastoma. / Fianco, Giulia; Contadini, Claudia; Ferri, Alessandra; Cirotti, Claudia; Stagni, Venturina; Barilà, Daniela.

In: International Journal of Molecular Sciences, Vol. 19, No. 12, 3798, 01.12.2018.

Research output: Contribution to journalReview article

Fianco, Giulia ; Contadini, Claudia ; Ferri, Alessandra ; Cirotti, Claudia ; Stagni, Venturina ; Barilà, Daniela. / Caspase-8 : A novel target to overcome resistance to chemotherapy in glioblastoma. In: International Journal of Molecular Sciences. 2018 ; Vol. 19, No. 12.
@article{6fe9e6ba557a4042a3b63eac7ff8175a,
title = "Caspase-8: A novel target to overcome resistance to chemotherapy in glioblastoma",
abstract = "Caspase-8 was originally identified as a central player of programmed cell death triggered by death receptor stimulation. In that context, its activity is tightly regulated through several mechanisms, with the best established being the expression of FLICE-like inhibitory protein (FLIP) family proteins and the Src-dependent phosphorylation of Caspase-8 on Tyr380. Loss of apoptotic signaling is a hallmark of cancer and indeed Caspase-8 expression is often lost in tumors. This event may account not only for cancer progression but also for cancer resistance to radiotherapy and chemotherapy. Intriguingly, other tumors, such as glioblastoma, preferentially retain Caspase-8 expression, and high levels of Caspase-8 expression may correlate with a worse prognosis, suggesting that in this context this protease loses its apoptotic activity and gains additional functions. Using different cellular systems, it has been clearly shown that in cancer Caspase-8 can exhibit non-canonical functions, including promotion of cell adhesion, migration, and DNA repair. Intriguingly, in glioblastoma models, Caspase-8 can promote NF-κB-dependent expression of several cytokines, angiogenesis, and in vitro and in vivo tumorigenesis. Overall, these observations suggest that some cancer cells may hijack Caspase-8 function which in turn promote cancer progression and resistance to therapy. Here we aim to highlight the multiple functions of Caspase-8 and to discuss whether the molecular mechanisms that modulate the balance between those functions may be targeted to dismantle the aberrant activity of Caspase-8 and to restore its canonical apoptotic functionality.",
keywords = "Apoptosis, Caspase-8, Chemotherapy and radiotherapy, DNA damage, FLIP, Glioblastoma, NF-κB, Src kinase, Tumor microenvironment, Tyrosine phosphorylation",
author = "Giulia Fianco and Claudia Contadini and Alessandra Ferri and Claudia Cirotti and Venturina Stagni and Daniela Baril{\`a}",
year = "2018",
month = "12",
day = "1",
doi = "10.3390/ijms19123798",
language = "English",
volume = "19",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "MDPI AG",
number = "12",

}

TY - JOUR

T1 - Caspase-8

T2 - A novel target to overcome resistance to chemotherapy in glioblastoma

AU - Fianco, Giulia

AU - Contadini, Claudia

AU - Ferri, Alessandra

AU - Cirotti, Claudia

AU - Stagni, Venturina

AU - Barilà, Daniela

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Caspase-8 was originally identified as a central player of programmed cell death triggered by death receptor stimulation. In that context, its activity is tightly regulated through several mechanisms, with the best established being the expression of FLICE-like inhibitory protein (FLIP) family proteins and the Src-dependent phosphorylation of Caspase-8 on Tyr380. Loss of apoptotic signaling is a hallmark of cancer and indeed Caspase-8 expression is often lost in tumors. This event may account not only for cancer progression but also for cancer resistance to radiotherapy and chemotherapy. Intriguingly, other tumors, such as glioblastoma, preferentially retain Caspase-8 expression, and high levels of Caspase-8 expression may correlate with a worse prognosis, suggesting that in this context this protease loses its apoptotic activity and gains additional functions. Using different cellular systems, it has been clearly shown that in cancer Caspase-8 can exhibit non-canonical functions, including promotion of cell adhesion, migration, and DNA repair. Intriguingly, in glioblastoma models, Caspase-8 can promote NF-κB-dependent expression of several cytokines, angiogenesis, and in vitro and in vivo tumorigenesis. Overall, these observations suggest that some cancer cells may hijack Caspase-8 function which in turn promote cancer progression and resistance to therapy. Here we aim to highlight the multiple functions of Caspase-8 and to discuss whether the molecular mechanisms that modulate the balance between those functions may be targeted to dismantle the aberrant activity of Caspase-8 and to restore its canonical apoptotic functionality.

AB - Caspase-8 was originally identified as a central player of programmed cell death triggered by death receptor stimulation. In that context, its activity is tightly regulated through several mechanisms, with the best established being the expression of FLICE-like inhibitory protein (FLIP) family proteins and the Src-dependent phosphorylation of Caspase-8 on Tyr380. Loss of apoptotic signaling is a hallmark of cancer and indeed Caspase-8 expression is often lost in tumors. This event may account not only for cancer progression but also for cancer resistance to radiotherapy and chemotherapy. Intriguingly, other tumors, such as glioblastoma, preferentially retain Caspase-8 expression, and high levels of Caspase-8 expression may correlate with a worse prognosis, suggesting that in this context this protease loses its apoptotic activity and gains additional functions. Using different cellular systems, it has been clearly shown that in cancer Caspase-8 can exhibit non-canonical functions, including promotion of cell adhesion, migration, and DNA repair. Intriguingly, in glioblastoma models, Caspase-8 can promote NF-κB-dependent expression of several cytokines, angiogenesis, and in vitro and in vivo tumorigenesis. Overall, these observations suggest that some cancer cells may hijack Caspase-8 function which in turn promote cancer progression and resistance to therapy. Here we aim to highlight the multiple functions of Caspase-8 and to discuss whether the molecular mechanisms that modulate the balance between those functions may be targeted to dismantle the aberrant activity of Caspase-8 and to restore its canonical apoptotic functionality.

KW - Apoptosis

KW - Caspase-8

KW - Chemotherapy and radiotherapy

KW - DNA damage

KW - FLIP

KW - Glioblastoma

KW - NF-κB

KW - Src kinase

KW - Tumor microenvironment

KW - Tyrosine phosphorylation

UR - http://www.scopus.com/inward/record.url?scp=85057972427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85057972427&partnerID=8YFLogxK

U2 - 10.3390/ijms19123798

DO - 10.3390/ijms19123798

M3 - Review article

AN - SCOPUS:85057972427

VL - 19

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 12

M1 - 3798

ER -